Manchester Financial Inc Lipocine Inc. Transaction History

Manchester Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 26, 2021	SELL	$1.2 - $1.69 $600 - $845	-500 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$0.32 - $3.15 $160 - $1,575	500 New	500 $0
Q3 2019 Oct 09, 2019	SELL	$1.79 - $3.33 $895 - $1,665	-500 Closed	0 $0
Q2 2019 Jul 23, 2019	BUY	$1.43 - $2.32 $715 - $1,160	500 New	500 $1,000

Ticker LPCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,510,800
Market Cap $434M
Description
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Manchester Financial Inc with notifications on news.